Pain Control After Minimally Invasive Coronary Artery Bypass Grafting
Stopped early · Phase 4
Conditions studied: Postoperative Pain, Medication Side Effects, Narcotic Requirement
In brief
The purpose of this study is to compare postoperative pain control after minimally invasive coronary artery bypass grafting for patients who receive an intercostal block (an anesthetic medicine injected in an area under the ribs) in the operating room and IV acetaminophen (Tylenol) to those who receive an intercostal block and On-Q pain pump catheter (a balloon pump attached to 2 small tubes near your procedure site that automatically delivers pain medicine).
Key facts
- Study ID
- NCT01770236
- Run by
- Gundersen Lutheran Medical Foundation
- People needed
- 41
- Starts
- 2013-01-01
- Expected to finish
- 2015-11-01
- Last updated by the study team
- 2016-12-21
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age or older
- Coronary artery disease requiring surgical intervention
- No prior sternotomy
- Creatinine within normal limits (0.60 - 1.10 mg/dL)
You may not qualify if…
- Less than 18 years of age
- Inability to provide consent or complete a written survey
- Previous history of sternotomy
- Contraindications to MICS-CABG or to any of the components of the 2 analgesic regimens
Where it is running
- Gundersen Lutheran Health System — La Crosse, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.